Section Arrow
Quote
QNRX.NASDAQ
- Quoin Pharmaceuticals Ltd
Quotes are at least 15-min delayed:2025/11/16 02:46 EST
Regular Hours
Last
 15.03
+1.61 (+12.00%)
Day High 
15.4999 
Prev. Close
13.42 
1-M High
18.99 
Volume 
178.98K 
Bid
14.32
Ask
14.65
Day Low
12.2601 
Open
13.04 
1-M Low
8.0501 
Market Cap 
11.26M 
Currency USD 
P/E 0.01 
%Yield -- 
10-SMA 10.39 
20-SMA 11.98 
50-SMA 10.13 
52-W High 48.3 
52-W Low 5.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-37.55/-6.23
Enterprise Value
11.26M
Balance Sheet
Book Value Per Share
-1.45
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed：2025/11/16 02:46 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively havethe potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.